Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Any retinitis pigmentosa in which the cause of the disease is a mutation in the SLC7A14 gene.
Features include always present findings: Bone spicule pigmentation of the retina, Nyctalopia, Visual field defect, and Reduced visual acuity and others.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Bones and joints | 1 | Bone spicule pigmentation of the retina |
SLC7A14 function has not been fully characterized.
Retinitis pigmentosa 68 is associated with mutations in the SLC7A14 gene on chromosome 3.
Genetic testing for SLC7A14 is available. Testing is considered confirmatory for diagnosis.
Biomarker and diagnostic research for retinitis pigmentosa 68 has been reported in the published literature.
Phenotype severity distribution: 6 always present features.
No clinical trials have been registered for retinitis pigmentosa 68.
48 publications have been identified in PubMed for retinitis pigmentosa 68. Research spans Epidemiology / Natural History (42%), Basic Science / Preclinical (21%), and Diagnostic / Biomarker (15%).
Research Type | Count | % of Total |
|---|---|---|
Disease patterns and progression | 20 | 42% |
Data assembled from 5 of 12 sources · Last updated Sep 18, 2026, 11:47 PM UTC
Online Mendelian Inheritance in Man
Genetic and Rare Diseases Info Center
1 |
Retinal atrophy |
Muscles | 1 | Retinal atrophy |
Age of onset: childhood.
Laboratory research
10 |
21% |
Testing and diagnosis research | 7 | 15% |
Clinical study results | 7 | 15% |
Research summaries | 2 | 4% |
Patient case studies | 2 | 4% |
Na H (2026). [PMID: 42256003](https://pubmed.ncbi.nlm.nih.gov/42256003/). *Ophthalmol Sci*. [Basic Science / Preclinical]
Josan AS (2026). [PMID: 41237986](https://pubmed.ncbi.nlm.nih.gov/41237986/). *Am J Ophthalmol*. [Epidemiology / Natural History]
Appelbaum T (2026). [PMID: 41649227](https://pubmed.ncbi.nlm.nih.gov/41649227/). *Invest Ophthalmol Vis Sci*. [Basic Science / Preclinical]
Dones AM (2026). [PMID: 41248229](https://pubmed.ncbi.nlm.nih.gov/41248229/). *Retina*. [Diagnostic / Biomarker]
Sattari S (2026). [PMID: 40643847](https://pubmed.ncbi.nlm.nih.gov/40643847/). *Mol Biotechnol*. [Basic Science / Preclinical]
Lee CH (2026). [PMID: 41213528](https://pubmed.ncbi.nlm.nih.gov/41213528/). *Ophthalmic Genet*. [Epidemiology / Natural History]
Hong Y (2026). [PMID: 41242591](https://pubmed.ncbi.nlm.nih.gov/41242591/). *Am J Ophthalmol*. [Epidemiology / Natural History]
Kadyshev VV (2026). [PMID: 41847810](https://pubmed.ncbi.nlm.nih.gov/41847810/). *Vestn Oftalmol*. [Basic Science / Preclinical]
Kim J (2026). [PMID: 42001345](https://pubmed.ncbi.nlm.nih.gov/42001345/). *Hum Cell*. [Basic Science / Preclinical]
Eriksen KO (2026). [PMID: 40977613](https://pubmed.ncbi.nlm.nih.gov/40977613/). *Acta Ophthalmol*. [Epidemiology / Natural History]